Harsanyi Zsolt
SEC insider (Form 3/4/5 filer). CIK 0001380184. Director at Aptevo Therapeutics Inc. (APVO) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Aug 6, 2026. Located in SEATTLE, WA.
Companies Harsanyi Zsolt has filed insider reports for
- Aptevo Therapeutics Inc. (APVO): Director
- Emergent BioSolutions Inc. (EBS): Director, Officer, Chairman
Harsanyi Zsolt
CIK: 0001380184
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)2 (40.0%)
Derivative conversions
Awards (A)3 (60.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 6, 2026APVO
Aptevo Therapeutics Inc.
ExerciseDirect400 shares- - Apr 30, 2026EBS
Emergent BioSolutions Inc.
AwardDirect25.3K shares- - Aug 6, 2025APVO
Aptevo Therapeutics Inc.
AwardDirectRestricted Stock Unit
7.2K shares- - Jul 17, 2025APVO
Aptevo Therapeutics Inc.
ExerciseDirect1 shares- - Apr 30, 2025EBS
Emergent BioSolutions Inc.
AwardDirect34.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 6, 2026 |  APVO Aptevo Therapeutics Inc. | Exercise | 400 | - | $0 | Direct |
| Apr 30, 2026 |  EBS Emergent BioSolutions Inc. | Award | 25,344 | - | $0 | Direct |
| Aug 6, 2025 | APVO Aptevo Therapeutics Inc. | Award Restricted Stock Unit | 7,200 | - | - | Direct |
| Jul 17, 2025 | APVO Aptevo Therapeutics Inc. | Exercise | 1 | - | - | Direct |
| Apr 30, 2025 | EBS Emergent BioSolutions Inc. | Award | 34,403 | - | - | Direct |
1-5 of 5 transactions